Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mm

1 Dec 2020

Abstract excerpt

OBJECTIVE: To examine the risk of clinically significant chromosomal microarray analysis findings in fetuses with nuchal translucency from 3.0-3.4 mm. In addition, we aimed to define the yield of noninvasive prenatal testing (NIPT) in such pregnancies. METHODS: This retrospective cohort study included results of all chromosomal microarray analysis tests performed owing to a nuchal translucency measurement from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33278279
DOI: 10.1097/aog.0000000000004195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mmPMID 33278279Read ↗

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimesterSemantic proximity Read ↗

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature reviewSemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Application of chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35Semantic proximity Read ↗

Diagnostic yield of chromosomal microarray analysis in fetuses with isolated increased nuchal translucency: a French multicenter studySemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Increased nuchal translucency with normal karyotype and genomic microarray analysis: A multicenter observational studySemantic proximity Read ↗

Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mmSemantic proximity Read ↗

Microarray and RASopathy‐disorder testing in fetuses with increased nuchal translucencySemantic proximity Read ↗

Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.